242 related articles for article (PubMed ID: 9218753)
1. Diabetes results from a late change in the autoimmune response of NOD mice.
Gazda LS; Charlton B; Lafferty KJ
J Autoimmun; 1997 Jun; 10(3):261-70. PubMed ID: 9218753
[TBL] [Abstract][Full Text] [Related]
2. Autoimmune diabetes: the involvement of benign and malignant autoimmunity.
Dilts SM; Lafferty KJ
J Autoimmun; 1999 Jun; 12(4):229-32. PubMed ID: 10330293
[TBL] [Abstract][Full Text] [Related]
3. Role of ICOS pathway in autoimmune and alloimmune responses in NOD mice.
Ansari MJ; Fiorina P; Dada S; Guleria I; Ueno T; Yuan X; Trikudanathan S; Smith RN; Freeman G; Sayegh MH
Clin Immunol; 2008 Feb; 126(2):140-7. PubMed ID: 17889619
[TBL] [Abstract][Full Text] [Related]
4. Islet mass plays a critical role in initiation, but not progression, of the diabetogenic process in NOD mice.
Kimura T; Ito A; Hancock WW; Maki T
J Autoimmun; 1999 Jun; 12(4):243-9. PubMed ID: 10330295
[TBL] [Abstract][Full Text] [Related]
5. Immunological reversal of autoimmune diabetes without hematopoietic replacement of beta cells.
Suri A; Calderon B; Esparza TJ; Frederick K; Bittner P; Unanue ER
Science; 2006 Mar; 311(5768):1778-80. PubMed ID: 16556846
[TBL] [Abstract][Full Text] [Related]
6. Isolation of self antigen-reactive cells from inflamed islets of nonobese diabetic mice using CD4high expression as a marker.
Lejon K; Fathman CG
J Immunol; 1999 Nov; 163(10):5708-14. PubMed ID: 10553102
[TBL] [Abstract][Full Text] [Related]
7. Transfer of diabetes from prediabetic NOD mice to NOD-SCID/SCID mice: association with pancreatic insulin content.
Füchtenbusch M; Larger E; Thebault K; Boitard C
Horm Metab Res; 2005 Feb; 37(2):63-7. PubMed ID: 15778920
[TBL] [Abstract][Full Text] [Related]
8. Impact of donor immune cells in pancreatic islet transplantation.
Carter JD; Chen M; Ellett JD; Smith KM; Nadler JL; Yang Z
Transplant Proc; 2004 Nov; 36(9):2866-8. PubMed ID: 15621170
[TBL] [Abstract][Full Text] [Related]
9. Transplanted islets from lpr mice are resistant to autoimmune destruction in a model of streptozotocin-induced type I diabetes.
Vijayan S; Zhou P; Rajapaksha TW; Alegre M-; Peter ME
Apoptosis; 2005 Aug; 10(4):725-30. PubMed ID: 16133864
[TBL] [Abstract][Full Text] [Related]
10. Loss of glucose transporter-2 precedes insulin loss in the nonobese diabetic and the low-dose streptozotocin mouse models: a comparative immunohistochemical study by light and confocal microscopy.
Reddy S; Young M; Poole CA; Ross JM
Gen Comp Endocrinol; 1998 Jul; 111(1):9-19. PubMed ID: 9653017
[TBL] [Abstract][Full Text] [Related]
11. Reversal of diabetes in non-obese diabetic mice without spleen cell-derived beta cell regeneration.
Chong AS; Shen J; Tao J; Yin D; Kuznetsov A; Hara M; Philipson LH
Science; 2006 Mar; 311(5768):1774-5. PubMed ID: 16556844
[TBL] [Abstract][Full Text] [Related]
12. Persistence of residual beta cells and islet autoimmunity during increasing duration of diabetes in NOD mice and experimental approaches toward reversing new-onset disease with bioactive peptides.
Reddy S; Cheung CC; Chai RC; Rodrigues JA
Ann N Y Acad Sci; 2008 Dec; 1150():171-6. PubMed ID: 19120289
[TBL] [Abstract][Full Text] [Related]
13. Indefinite islet protection from autoimmune destruction in nonobese diabetic mice by agarose microencapsulation without immunosuppression.
Kobayashi T; Aomatsu Y; Iwata H; Kin T; Kanehiro H; Hisanaga M; Ko S; Nagao M; Nakajima Y
Transplantation; 2003 Mar; 75(5):619-25. PubMed ID: 12640299
[TBL] [Abstract][Full Text] [Related]
14. Islet regeneration during the reversal of autoimmune diabetes in NOD mice.
Kodama S; Kühtreiber W; Fujimura S; Dale EA; Faustman DL
Science; 2003 Nov; 302(5648):1223-7. PubMed ID: 14615542
[TBL] [Abstract][Full Text] [Related]
15. CD4+CD25+ regulatory T cells control the progression from periinsulitis to destructive insulitis in murine autoimmune diabetes.
Ott PA; Anderson MR; Tary-Lehmann M; Lehmann PV
Cell Immunol; 2005 May; 235(1):1-11. PubMed ID: 16122720
[TBL] [Abstract][Full Text] [Related]
16. Gene transfection and expression of transforming growth factor-beta1 in nonobese diabetic mouse islets protects beta-cells in syngeneic islet grafts from autoimmune destruction.
Suarez-Pinzon WL; Marcoux Y; Ghahary A; Rabinovitch A
Cell Transplant; 2002; 11(6):519-28. PubMed ID: 12428741
[TBL] [Abstract][Full Text] [Related]
17. I-Ag7-mediated antigen presentation by B lymphocytes is critical in overcoming a checkpoint in T cell tolerance to islet beta cells of nonobese diabetic mice.
Noorchashm H; Lieu YK; Noorchashm N; Rostami SY; Greeley SA; Schlachterman A; Song HK; Noto LE; Jevnikar AM; Barker CF; Naji A
J Immunol; 1999 Jul; 163(2):743-50. PubMed ID: 10395666
[TBL] [Abstract][Full Text] [Related]
18. Contribution of T cells to the development of autoimmune diabetes in the NOD mouse model.
Toyoda H; Formby B
Bioessays; 1998 Sep; 20(9):750-7. PubMed ID: 9819564
[TBL] [Abstract][Full Text] [Related]
19. Abrogation of recurrent autoimmunity in the NOD mouse: A critical role for host interleukin 4.
Shi Q; Wang D; Hadley GA; Farber DL; Bartlett ST
Surgery; 2006 Aug; 140(2):281-8. PubMed ID: 16904981
[TBL] [Abstract][Full Text] [Related]
20. Autoimmunity triggers in the NOD mouse: a role for natural auto-antibody reactivities in type 1 diabetes.
Côrte-Real J; Duarte N; Tavares L; Penha-Gonçalves C
Ann N Y Acad Sci; 2009 Sep; 1173():442-8. PubMed ID: 19758184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
